Authors:
EMMERICH F
BARGOU RC
KRAPPMANN D
BOMMERT K
GREINER A
SCHEIDEREIT C
DORKEN B
Citation: F. Emmerich et al., NF-KAPPA-B ACTIVATION REQUIRED FOR PROLIFERATION AND APOPTOSIS-RESISTANCE OF HODGKINS-DISEASE TUMOR-CELLS, Blood, 90(10), 1997, pp. 1729-1729
Authors:
DANIEL PT
RITSCHEL S
BROWN R
PEZZUTTO A
KOHNE CH
DORKEN B
Citation: Pt. Daniel et al., BIK NBK-1, AN APOPTOSIS PROMOTING MEMBER OF THE BCL-2 FAMILY, INCREASES DRUG-SENSITIVITY MATURE T-LEUKEMIA-CELLS/, Blood, 90(10), 1997, pp. 2198-2198
Authors:
KARAWAJEW L
KOSSER A
RUPPERT V
MARTIN M
SCHRAPPE M
DORKEN B
LUDWIG WD
Citation: L. Karawajew et al., CAPABILITY OF IL-7 TO PREVENT IN-VITRO SPONTANEOUS APOPTOSIS OF T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) CELLS CORRELATES WITH A CORTICAL MATURE PHENOTYPE AND A GOOD INITIAL IN-VIVO RESPONSE TO CHEMOTHERAPY/, Blood, 90(10), 1997, pp. 2493-2493
Authors:
MAPARA MY
KORNER IJ
HILDEBRANDT M
BARGOU R
KRAHL D
REICHARDT P
DORKEN B
Citation: My. Mapara et al., MONITORING OF TUMOR-CELL PURGING AFTER HIGHLY EFFICIENT IMMUNOMAGNETIC SELECTION OF CD34 CELLS FROM LEUKAPHERESIS PRODUCTS IN BREAST-CANCERPATIENTS - COMPARISON OF IMMUNOCYTOCHEMICAL TUMOR-CELL STAINING AND REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION, Blood, 89(1), 1997, pp. 337-344
Citation: S. Cayeux et al., COEXPRESSION OF INTERLEUKIN-4 AND B7.1 IN MURINE TUMOR-CELLS LEADS TOIMPROVED TUMOR REJECTION AND VACCINE EFFECT COMPARED TO SINGLE-GENE TRANSFECTANTS AND A CLASSICAL ADJUVANT, Human gene therapy, 7(4), 1996, pp. 525-529
Authors:
BARGOU RC
WAGENER C
BOMMERT K
ARNOLD W
DANIEL PT
MAPARA MY
GRINSTEIN E
ROYER HD
DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF TRANSCRIPTION FACTOR E2F DP BY DOMINANT-NEGATIVE MUTANTS IN A NORMAL BREAST EPITHELIAL-CELL LINE EFFICIENTLY INHIBITS APOPTOSISAND INDUCES TUMOR-GROWTH IN SCID MICE/, The Journal of experimental medicine, 183(3), 1996, pp. 1205-1213
Authors:
WAGENER C
BARGOU RC
DANIEL PT
BOMMERT K
MAPARA MY
ROYER HD
DORKEN B
Citation: C. Wagener et al., INDUCTION OF THE DEATH-PROMOTING GENE BAX-ALPHA SENSITIZES CULTURED BREAST-CANCER CELLS TO DRUG-INDUCED APOPTOSIS, International journal of cancer, 67(1), 1996, pp. 138-141
Authors:
LUBBE AS
BERGEMANN C
RIESS H
SCHRIEVER F
REICHARDT P
POSSINGER K
MATTHIAS M
DORKEN B
HERRMANN F
GURTLER R
HOHENBERGER P
HAAS N
SOHR R
SANDER B
LEMKE AJ
OHLENDORF D
HUHNT W
HUHN D
Citation: As. Lubbe et al., CLINICAL-EXPERIENCES WITH MAGNETIC DRAG TARGETING - A PHASE-I STUDY WITH 4'-EPIDOXORUBICIN IN 14 PATIENTS WITH ADVANCED SOLID TUMORS, Cancer research, 56(20), 1996, pp. 4686-4693
Citation: K. Bommert et al., IDENTIFICATION OF CELL-DEATH ASSOCIATED GENES AFTER INDUCTION OF APOPTOSIS BY SURFACE IGM CROSS-LINKING IN THE HUMAN BURKITT-LYMPHOMA CELL-LINE BL41, Blood, 88(10), 1996, pp. 3450-3450
Authors:
DANIEL PT
KROIDL A
LANGNER K
KOHNE CH
DORKEN B
Citation: Pt. Daniel et al., INDUCTION OF THE CD95 (FAS APO-1) LIGAND - AN ALTERNATIVE MECHANISM IN CYTOSTATIC DRUG-INDUCED APOPTOSIS WHICH IS ACTIVE IN T-LYMPHOID BUT NOT B-LYMPHOID AND BREAST-CANCER CELLS/, Blood, 88(10), 1996, pp. 262-262
Authors:
DANIEL PT
HEMPEL C
BOMMERT K
BARGOU RC
MAPARA MY
DORKEN B
Citation: Pt. Daniel et al., TRIGGERING OF THE B-CELL ANTIGEN RECEPTOR PREVENTS CD95 (APO-1 FAS) MEDIATED APOPTOSIS OF CD40 LIGAND-ACTIVATED B-CELLS/, Blood, 88(10), 1996, pp. 640-640
Authors:
WESTERMANN J
AICHER A
FISHER C
DOHNER H
MAPARA M
DORKEN B
PEZZUTTO A
Citation: J. Westermann et al., USE OF DENDRITIC CELLS (DC) FOR THE INDUCTION OF ANTI BCR-ABL IMMUNITY IN CHRONIC MYELOID-LEUKEMIA - SUPERIORITY OF CD34-DERIVED DC, Blood, 88(10), 1996, pp. 908-908
Authors:
MAPARA MY
KORNER IJ
HILDEBRANDT M
BARGOU R
DORKEN B
Citation: My. Mapara et al., COMBINED POSITIVE AND NEGATIVE PURGING OF PERIPHERAL-BLOOD STEM-CELL AUTOGRAFTS IN BREAST-CANCER PATIENTS, Blood, 88(10), 1996, pp. 992-992
Authors:
CAYEUX S
RICHTER G
NOFFZ G
DORKEN B
BLANKENSTEIN T
Citation: S. Cayeux et al., INFLUENCE OF GENE MODIFIED (IL-7, IL-4 AND B7) TUMOR-CELL VACCINES ONTUMOR-ANTIGEN PRESENTATION, Blood, 88(10), 1996, pp. 1090-1090
Authors:
BARGOU RC
EMMERICH F
KRAPPMANN D
BOMMERT K
MAPARA MY
ARNOLD W
ROYER HD
SCHEIDEREIT C
DORKEN B
Citation: Rc. Bargou et al., BLOCKING OF NF-KAPPA-B BY DOMINANT-NEGATIVE IKB-ALPHA MUTANT IN THE HODGKIN CELL-LINE HD-MYZ REDUCES CELL-CYCLE PROGRESSION, PROMOTES APOPTOSIS AND SUPPRESSES TUMOR-GROWTH IN SCID MICE, Blood, 88(10), 1996, pp. 1527-1527
Authors:
SCHOTT G
SPERLING C
SCHRAPPE M
RATEI R
MARTIN M
MEYER U
DORKEN B
RIEHM H
LUDWIG WD
Citation: G. Schott et al., T-CELL RECEPTOR (TCR) GAMMA-DELTA-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA (T-ALL) - A SUBGROUP WITH DISTINCT IMMUNOPHENOTYPIC AND CLINICAL-FEATURES( T), Blood, 88(10), 1996, pp. 1793-1793
Authors:
KARAWAJEW L
WUCHTER C
RUPPERT V
DORKEN B
LUDWIG WD
Citation: L. Karawajew et al., DIFFERENTIAL SUSCEPTIBILITY TO CD95-INDUCED APOPTOSIS IN ACUTE MYELOID-LEUKEMIA (AML) - DEPENDENCE ON CD34-PHENOTYPE AND GROWTH-CHARACTERISTICS IN-VITRO, Blood, 88(10), 1996, pp. 2240-2240
Authors:
BARGOU RC
LENG C
KRAPPMANN D
EMMERICH F
MAPARA MY
BOMMERT K
ROYER HD
SCHEIDEREIT C
DORKEN B
Citation: Rc. Bargou et al., HIGH-LEVEL NUCLEAR NF-KAPPA-B AND OCT-2 IS A COMMON FEATURE OF CULTURED HODGKIN REED-STERNBERG CELLS/, Blood, 87(10), 1996, pp. 4340-4347
Authors:
BECK C
CAYEUX S
LUPTON SD
DORKEN B
BLANKENSTEIN T
Citation: C. Beck et al., THE THYMIDINE KINASE GANCICLOVIR-MEDIATED SUICIDE EFFECT IS VARIABLE IN DIFFERENT TUMOR-CELLS, Human gene therapy, 6(12), 1995, pp. 1525-1530
Authors:
REICHARDT P
LENTZSCH S
HOHENBERGER P
DORKEN B
Citation: P. Reichardt et al., SUCCESSFUL AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH CHONDROSARCOMA - A REPORT OF 4 CASES, European journal of cancer, 31A, 1995, pp. 869-869
Authors:
BARGOU RC
BOMMERT K
MAPARA MY
DANIEL PT
DORKEN B
Citation: Rc. Bargou et al., CONSTITUTIVE NUCLEAR-BINDING ACTIVITY OF NF-KAPPA-B AND OCT-2 ARE A COMMON AND SPECIFIC FEATURE OF CULTURED AND PRIMARY HODGKIN CELLS, Experimental hematology, 23(8), 1995, pp. 780-780
Authors:
DANIEL PT
MAPARA MY
BOMMERT K
BARGOU RC
KRAMMER P
DORKEN B
Citation: Pt. Daniel et al., CD95 (APO-1 FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS/, Experimental hematology, 23(8), 1995, pp. 831-831